On December 12, 2022, KIYATEC, Inc. closed the transaction. The transaction was led by new investor Bruker Corporation. The transaction also included participation from returning investors Laboratory Corporation of America Holdings, VentureSouth, and Seae Ventures.
Laboratory Corporation of America Holdings
Equities
LH
US50540R4092
Healthcare Facilities & Services
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
205.6 USD | +3.63% | +1.51% | -9.31% |
04:18pm | Labcorp Receives US FDA's Approval for Companion Diagnostic Device for Use With Pfizer's Hemophilia B Gene Therapy | MT |
03:55pm | US FDA publishes final rule for laboratory developed tests | RE |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
205.6 USD | +3.63% | +1.51% | 16.73B | ||
81.92 USD | +1.17% | +4.77% | 11.77B | ||
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.31% | 16.73B | |
-14.75% | 84.68B | |
+14.40% | 81.12B | |
+10.49% | 29.59B | |
-1.39% | 16.36B | |
-31.58% | 11.77B | |
+1.82% | 11.72B | |
+31.78% | 11.71B | |
-0.47% | 11.66B | |
-7.27% | 11.37B |
- Stock Market
- Equities
- LH Stock
- News Laboratory Corporation of America Holdings
- KIYATEC, Inc. announced that it has received $18.057766 million in funding from Bruker Corporation, Laboratory Corporation of America Holdings, VentureSouth, Seae Ventures